Resmed Inc. buy KeyCorp
Start price
26.04.24
/
50%
€190.40
Target price
26.04.25
€222.05
Performance (%)
14.77%
Price
19.09.24
€217.60
Summary
This prediction is currently active. The prediction currently has a performance of 14.77%. Dividends of €0.93 are taken into consideration when calculating the performance. This prediction currently runs until 26.04.25. The prediction end date can be changed by KeyCorp at any time. KeyCorp has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Resmed Inc. | -3.887% | -3.887% |
iShares Core DAX® | 2.291% | 2.984% |
iShares Nasdaq 100 | 1.336% | -0.196% |
iShares Nikkei 225® | 1.132% | 2.488% |
iShares S&P 500 | 1.272% | 1.334% |
Comments by KeyCorp for this prediction
In the thread Resmed Inc. diskutieren
ResMed Inc. (NYSE: RMD) had its price target raised by analysts at KeyCorp from $227.00 to $238.00. They now have an "overweight" rating on the stock.
Ratings data for RMD provided by MarketBeat